US2016052974A1PendingUtilityA1
Novel genes and proteins of brachyspira hyodysenteriae and uses thereof
Est. expiryAug 3, 2027(~1 yrs left)· nominal 20-yr term from priority
C07K 14/20G01N 33/56911A61P 37/04A61K 39/0225A61P 31/04A61K 2039/552G01N 2333/20
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel polynucleotide and amino acids of Brachyspira hyodysenteriae are described. These sequences are useful for diagnosis of B. hyodysenteriae disease in animals and as a therapeutic treatment or prophylactic treatment of B. hyodysenteriae disease in animals. These sequences may also be useful for diagnostic and therapeutic and/or prophylactic treatment of diseases in animals caused by other Brachyspira species, including B. intermedia, B. suantatina, B. alvinipulli, B. aalborgi, B. innocens, B. murdochii , and B. pilosicoli.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide comprising the full length of an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 with a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
2 - 5 . (canceled)
6 . An immunogenic composition comprising the polypeptide of claim 1 .
7 - 30 . (canceled)
31 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 1 .
32 - 44 . (canceled)
45 . An isolated polypeptide comprising a sequence that is at least 70% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
46 . An isolated polypeptide comprising a sequence that is at least 80% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
47 . An isolated polypeptide comprising a sequence that is at least 90% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
48 . An immunogenic composition comprising the polypeptide of claim 45 .
49 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 45 .
50 . An immunogenic composition comprising the polypeptide of claim 46 .
51 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 46 .
52 . An immunogenic composition comprising the polypeptide of claim 47 .
53 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 47 .Join the waitlist — get patent alerts
Track US2016052974A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.